The most important financial indicators for the company Aem Medical Investment Srl - Unique Identification Number 30812824:
sales in 2023 was
39.797
euro, registering a net profit of
2.887
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Inchirierea si subinchirierea bunurilor imobiliare proprii having the NACE code 6820.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -25.2%, from 53.351 euro in the year 2022, to 39.797 euro in 2023.
The Net Profit increased by 1.583 euro, from 1.308 euro in 2022, to 2.887 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Aem Medical Investment Srl - CUI 30812824
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
32.800
71.318
67.552
54.348
44.409
35.070
54.056
71.240
97.771
52.311
Current Assets
15.404
18.402
23.784
7.171
4.344
22.793
15.179
21.717
16.422
20.693
Inventories
3.972
2.002
1.313
193
2.237
5.765
8.782
10.311
3.275
5.262
Receivables
8.869
15.490
21.426
5.969
791
13.631
5.935
8.579
8.859
11.972
Cash
2.563
911
1.046
1.008
1.316
3.397
462
2.827
4.288
3.459
Shareholders Funds
-917
-21.419
-24.640
-18.922
-8.932
1.092
-14.314
-13.949
-12.684
-9.759
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
49.121
111.211
116.107
80.552
53.818
56.200
84.292
94.813
143.211
96.496
Income in Advance
0
0
0
0
3.868
619
0
18.909
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"6820 - 6820"
CAEN Financial Year
6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
20.693 euro in 2023 which includes Inventories of
5.262 euro, Receivables of
11.972 euro and cash availability of
3.459 euro.
The company's Equity was valued at
-9.759 euro, while total Liabilities amounted to
96.496 euro.
Equity increased by 2.887 euro, from -12.684 euro in 2022, to -9.759 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Aem Medical Investment Srl